# XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept

> **NCT03604159** · PHASE4 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 52 (actual)

## Conditions studied

- Opioid Dependence

## Interventions

- **DRUG:** Buprenorphine Extended Release
- **DRUG:** Sublingual Buprenorphine (SUBOXONE, Zubsolv, or generic tablets)

## Key facts

- **NCT ID:** NCT03604159
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-24
- **Primary completion:** 2020-05-04
- **Final completion:** 2020-05-04
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2022-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03604159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03604159, "XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03604159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*